The Annexure

News to 16 October 2026 ·

Desk›Healthcare› Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Ltd

BSE 544250 · NSE SANOFICONR · ISIN INE0UOS01011 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹4,213.65

+1.37%

BSE close, 28 August 2026

Market cap

₹9,704.30 cr

2.3 cr shares · Small cap

Free float

₹2,769.79 cr

as published

P/E · P/B

36.5× · 35.55×

EPS ₹115.50 · BV ₹118.53

FY25-25 rev / PAT

878.40 / 240.10

₹ cr, as filed

Filings, window

6

3 selected · 50%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹3,950.50 52-WK HIGH ₹5,394.00 ₹4,213.65 18% of range
Against 52-week high-21.9%
Against 52-week low+6.7%
Day change+1.37%
Size bandSmall cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹115.50
Price / earnings36.48×
Price / book35.55×
Book value — derived, price ÷ P/B₹118.53
Return on equity97.44%
Operating margin40.56%
Net margin29.19%

Consistency check

P/B ÷ P/E, which must equal ROE
97.45%
ROE as published
97.44%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 235.70 68.80 29.87 40.56% 29.19%
Mar-26 · Q 229.20 67.80 29.44 41.19% 29.58%
FY25-25 878.40 240.10 104.27 38.02% 27.33%

Quarter on quarter

Revenue, quarter on quarter
+2.8%
Net profit, quarter on quarter
+1.5%
Operating margin, quarter on quarter
-63 bps

Disclosure profile 6 filings in the window

0 median 17.0 p75 · 24 sector max 59 6 5th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 24 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Press Release1
Results1
Selected sub-total3
Procedural
Compliance Certificate1
Newspaper Publication1
Trading Window1
Procedural sub-total3
Total6

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

6 filings · 3 selected · busiest 2026-07-28

Filing rhythm · the twelve most recent

2026-07-282026-10-12

SelectedProcedural

Filings

6 in the window · 10 earlier on record

  1. 12 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026 is enclosed.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation for Closure of Trading Window.

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 30 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Copy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.

    Company Update / Newspaper Publication View filing →

  4. 28 July 2026 ·

    Press Release

    Press Release / Media Release

    The Board of Directors at its meeting held on Tuesday, 28th July 2026, considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this ....

    Company Update / Press Release / Media Release View filing →

  5. 28 July 2026 ·

    Results

    Results - Financial Results For June 30, 2026

    Unaudited Financial Results for the quarter and half year ended June 30, 2026 is enclosed.

    Result / Financial Results View filing →

  6. 28 July 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, 28Th July 2026

    We wish to inform you that the Board of Directors at its meeting held today, i.e. Tuesday, 28th July 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Sanofi Consumer Healthcare India Ltd · the 50 most recent filings